Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
18 janv. 2022 07h00 HE
|
Sema4
Business combination projected to deliver $350 million in pro forma 2022 revenue $200 million private placement from leading growth and life sciences investors, including Pfizer, will fortify...
Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
10 janv. 2022 07h15 HE
|
Sema4
STAMFORD, Conn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced preliminary revenue (unaudited) for the...
Insights on the eClinical Solutions Global Market to 2026 - Featuring Acceliant, Bioclinica and Medrio Among Others
07 janv. 2022 05h03 HE
|
Research and Markets
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "eClinical Solutions Market Research Report by Product, Delivery Mode, Development Phase, End-user, and Region - Global Forecast to 2026 - Cumulative...
Q-Centrix and Realyze Intelligence Partner to Advance the Automation of High-Quality Clinical Data and Drive Better Patient Care
06 janv. 2022 09h00 HE
|
Q-Centrix
CHICAGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced a partnership with...
Global Electronic Health Record (EHR) Markets, 2021-2026 - Rapid Increase in Digitalization and Growing Competition to Positively Impact the Market
06 janv. 2022 04h38 HE
|
Research and Markets
Dublin, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The "Electronic Health Record Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global electronic...
Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January
03 janv. 2022 16h05 HE
|
Sema4
STAMFORD, Conn., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, PhD, Founder and...
Q-Centrix Launches First-of-its-Kind, Comprehensive Oncology Solution Within its' Enterprise Clinical Data Management (eCDM™) Platform
09 déc. 2021 09h00 HE
|
Q-Centrix
CHICAGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced the launch of the first...
Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studien
03 déc. 2021 02h00 HE
|
Immunicum AB
Pressmeddelande 3 december 2021 Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studienImmunicum AB (“Immunicum”, publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på...
Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study
03 déc. 2021 02h00 HE
|
Immunicum AB
Press Release Stockholm, Sweden, December 3, 2021 Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study Immunicum AB (“Immunicum”, publ; IMMU.ST), a biopharmaceutical...
Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia
16 nov. 2021 07h00 HE
|
Imara, Inc.
Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine was generally well-tolerated in this patient population ...